Teacher Retirement System of Texas’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$55.5M Buy
124,317
+13,307
+12% +$6.2M 0.23% 92
2025
Q4
$50.3M Sell
111,010
-7,638
-6% -$3.29M 0.17% 115
2025
Q3
$46.5M Sell
118,648
-3,725
-3% -$1.56M 0.19% 115
2025
Q2
$54.5M Sell
122,373
-4,451
-4% -$2.05M 0.23% 96
2025
Q1
$61.5M Buy
126,824
+21,929
+21% +$10.2M 0.26% 73
2024
Q4
$42.2M Buy
104,895
+22,165
+27% +$10.3M 0.15% 157
2024
Q3
$38.5M Buy
82,730
+9,383
+13% +$4.51M 0.18% 139
2024
Q2
$34.4M Buy
73,347
+1,434
+2% +$622K 0.2% 116
2024
Q1
$30.1M Buy
71,913
+11,570
+19% +$4.89M 0.19% 122
2023
Q4
$24.6M Sell
60,343
-7,828
-11% -$2.89M 0.17% 142
2023
Q3
$23.7M Buy
68,171
+1,106
+2% +$387K 0.16% 158
2023
Q2
$23.6M Sell
67,065
-20,138
-23% -$6.79M 0.16% 152
2023
Q1
$27.5M Sell
87,203
-53,927
-38% -$16.2M 0.18% 115
2022
Q4
$40.8M Sell
141,130
-4,984
-3% -$1.52M 0.3% 60
2022
Q3
$42.3M Buy
146,114
+5,874
+4% +$1.69M 0.31% 59
2022
Q2
$39.5M Sell
140,240
-22,306
-14% -$5.97M 0.27% 70
2022
Q1
$42.4M Buy
162,546
+49,786
+44% +$11.8M 0.22% 102
2021
Q4
$24.8M Sell
112,760
-16,482
-13% -$3.21M 0.11% 201
2021
Q3
$23.4M Sell
129,242
-63,131
-33% -$12.3M 0.13% 195
2021
Q2
$38.8M Buy
192,373
+16,775
+10% +$3.51M 0.21% 116
2021
Q1
$37.7M Sell
175,598
-81,250
-32% -$17.8M 0.21% 124
2020
Q4
$60.7M Buy
256,848
+55,920
+28% +$12.8M 0.37% 66
2020
Q3
$54.7M Buy
200,928
+54,200
+37% +$15M 0.35% 68
2020
Q2
$42.6M Buy
146,728
+57,160
+64% +$15.5M 0.35% 71
2020
Q1
$21.3M Buy
89,568
+38,184
+74% +$8.76M 0.23% 120
2019
Q4
$11.3M Buy
51,384
+25,977
+102% +$5.26M 0.09% 284
2019
Q3
$4.3M Sell
25,407
-5,688
-18% -$1.01M 0.04% 414
2019
Q2
$5.7M Buy
+31,095
New +$5.44M 0.05% 393
2019
Q1
Sell
-3,495
Closed -$579K 615
2018
Q4
$579K Sell
3,495
-26,518
-88% -$4.59M 0.01% 483
2018
Q3
$5.79M Sell
30,013
-21,492
-42% -$3.83M 0.04% 397
2018
Q2
$8.75M Sell
51,505
-4,460
-8% -$691K 0.06% 376
2018
Q1
$9.12M Sell
55,965
-43,156
-44% -$7.05M 0.06% 336
2017
Q4
$14.9M Buy
99,121
+95,730
+2,823% +$14.2M 0.1% 231
2017
Q3
$516K Buy
3,391
+730
+27% +$110K ﹤0.01% 642
2017
Q2
$343K Buy
2,661
+113
+4% +$13.6K ﹤0.01% 669
2017
Q1
$279K Buy
+2,548
New +$224K ﹤0.01% 772
2016
Q4
Sell
-9,490
Closed -$828K 1282
2016
Q3
$828K Sell
9,490
-8,052
-46% -$761K 0.01% 562
2016
Q2
$1.51M Sell
17,542
-191,495
-92% -$16.5M 0.01% 528
2016
Q1
$16.6M Buy
209,037
+203,073
+3,405% +$18.4M 0.11% 197
2015
Q4
$750K Sell
5,964
-7,072
-54% -$854K 0.01% 546
2015
Q3
$1.36M Buy
13,036
+3,621
+38% +$465K 0.01% 480
2015
Q2
$1.16M Buy
9,415
+2,126
+29% +$268K 0.01% 452
2015
Q1
$860K Buy
7,289
+78
+1% +$9.35K 0.01% 498
2014
Q4
$857K Buy
+7,211
New +$812K 0.01% 424
2014
Q3
Sell
-431
Closed -$41K 2439
2014
Q2
$41K Buy
+431
New +$30.2K ﹤0.01% 1526
2013
Q4
Sell
-3,617
Closed -$274K 2427
2013
Q3
$274K Buy
3,617
+1,089
+43% +$86.7K ﹤0.01% 959
2013
Q2
$202K Buy
+2,528
New +$186K ﹤0.01% 755

Other funds holding VRTX

Teacher Retirement System of Texas's VRTX Position: Q1 2026 in Review

Teacher Retirement System of Texas increased its Vertex Pharmaceuticals (VRTX) stake by 12% in Q1 2026, buying an estimated $6.2M and bringing the position to 124,317 shares worth $55.5M. The position accounts for 0.23% of the portfolio, ranked #92.

Teacher Retirement System of Texas first reported a position in VRTX in Q2 2013 and has held it in 47 quarters since. The position peaked at $61.5M in Q1 2025. 1,691 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Teacher Retirement System of Texas held 124,317 shares of Vertex Pharmaceuticals worth $55.5M as of Q1 2026.
  • Teacher Retirement System of Texas bought 13,307 Vertex Pharmaceuticals shares in Q1 2026, an estimated $6.2M.
  • Vertex Pharmaceuticals made up 0.23% of Teacher Retirement System of Texas's portfolio in Q1 2026, its #92 holding.
  • Teacher Retirement System of Texas first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 47 quarters since.
  • Teacher Retirement System of Texas's Vertex Pharmaceuticals position peaked at $61.5M in Q1 2025.
  • 1,691 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Teacher Retirement System of Texas's 13F filing for Q1 2026, filed 30 Apr 2026.